In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Merck trades 25.9% below a high-confidence fair value of $161.59, driven by strong DCF and profitability scores but limited growth (1.00/5). Monte Carlo shows wide valuation volatility (SD $265.72) with 33.3% downside risk below current price, indicating investment uncertainty amid stable fundamentals.